Armata Pharmaceuticals Inc
|Market Cap (Intraday)||80.85M|
|2yr Forward PE||N/A|
Armata Pharmaceuticals Inc Stock, ASE:ARMP
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.